Skip to Main Content
Skip Nav Destination

Editorial Board

Editor-in-Chief

Aung Naing, MD, FACP
Professor, Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Editorial Board Members

Jibran Ahmed, MD
Assistant Research Physician, Developmental Therapeutics Clinic, National Cancer Institute, National Institutes of Health, Bethesda, MD

Karen Autio, MD, MSc
Assistant Attending, Genitourinary Oncology Service and Early Drug Development Service, Memorial Sloan Kettering Cancer Center, New York, NY

Jyoti Bajpai, MD
Professor, Department of Medical Oncology, Tata Memorial Centre, Parel, Mumbai, India

Mehmet Asim Bilen, MD
Associate Professor and Director, Genitourinary Medical Oncology Program, Emory University, Atlanta, GA, USA

Helen Chen, MD
Senior Investigator and Medical Officer, Associate Chief, Investigational Drug Branch, Cancer Therapy Evaluation Program (CTEP), National Cancer Institute, Bethesda, MD, USA

Naval Daver, MD
Associate Professor, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Ecaterina Dumbrava, MD
Assistant Professor, Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Gerald Falchook, MD, MS
Director, Drug Development Unit, Sarah Cannon Research Institute at HealthONE, Denver, CO, USA 

Joud Hajjar, MD, PhD, MS
Associate Professor and Service Chief, Adult Allergy and Immunology, Division of Immunology, Allergy, and Rheumatology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA

Rebecca Harrison, MD
BC Cancer, Vancouver, BC, Canada

Sungjune Kim, MD, PhD
Vice Chair of Research and Director of Preclinical & Translational Research, Department of Radiation Oncology, Mayo Clinic Alix College of Medicine & Health Sciences, Jacksonville, FL, USA

Matthew Krebs, MD
Clinical Senior Lecturer, Division of Cancer Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester; Consultant in Medical Oncology, Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK

Vladimir Lazar, MD, PhD
Chief Scientific and Operating Officer, Worldwide Innovative Network (WIN) Association - WIN Consortium, Villejuif, France

Yisheng Li, PhD
Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Chia-Chi Lin, MD, PhD
Director of Phase 1 Center, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan

Sewanti Limaye MS, MBBS, MD
Department of Clinical and Translational Research Oncology, Department of Precision Oncology, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, India

Sanam Loghavi, MD
Assistant Professor, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Herbert Loong, MD
Clinical Associate Professor, Department of Clinical Oncology; Deputy Medical Director, Phase 1 Clinical Trials Centre, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China

Juanita Lopez, MD
Consultant in Medical Oncology, Drug Development Phase 1 Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, UK

Christophe Massard, MD
Department of Drug Development (DITEP), Gustave Roussy, Villejuif, France; Centre Eugène Marquis, Rennes, France; INSERM U1030, Université Paris-Saclay, Gif-sur-Yvette, France 

Gil Morgan, MD
Department of Oncology, Skåne University Hospital, Lund, Sweden

Mirella Nardo, MD
Department of Clinical Oncology, ICESP – Instituto do Cancer do Estado de Sao Paulo, SP, Brazil

Paolo Nuciforo, MD
Principal Investigator, Molecular Oncology Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, Barcelona, Spain

Haeseong Park, MD MPH
Co-Director, Developmental Therapeutics (Phase I) Program, Division of Oncology, Alvin J Siteman Cancer Center, Washington University in Saint Louis, St. Louis, MO, USA

Naveen Pemmaraju, MD
Associate Professor, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Jordi Rodon Ahnert, MD
Associate Professor, Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Christian Rolfo, MD
Associate Director of Clinical Research, Center for Thoracic Oncology, The Tisch Cancer Institute, Mount Sinai Health System; Professor, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Patricia Roxburgh, MD
Senior Clinical Lecturer, Experimental Therapeutics, Institute of Cancer Sciences, University of Glasgow; Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK

Ajay Sheshadri, MD
Associate Professor, Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Bettzy Stephen, MD
Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Shannon N. Westin, MD, MPH, FACOG
Director, Early Drug Development, Gynecologic Oncology and Reproductive Medicine, The University of Texas UT MD Anderson Cancer Center, Houston, TX, USA

Eddy Yang, MD, PhD
Professor and Markey Cancer Foundation Chair, Department of Radiation Medicine, Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, USA

Close Modal

or Create an Account

Close Modal
Close Modal